XML 38 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
Intangible Assets, Net (Details) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Intangible assets      
Gross carrying amount $ 6,449,628us-gaap_IntangibleAssetsGrossExcludingGoodwill $ 7,779,000us-gaap_IntangibleAssetsGrossExcludingGoodwill  
Accumulative Amortization   (87,318)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization  
Intangible assets, net 6,449,628us-gaap_IntangibleAssetsNetExcludingGoodwill 7,691,682us-gaap_IntangibleAssetsNetExcludingGoodwill  
Amortization of definite lived intangible assets 554,338us-gaap_AmortizationOfIntangibleAssets    
Impairment of intangible assets, excluding goodwill 6,670,345us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill 1,935,621us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill  
Impairment of finite lived intangibles 3,635,345us-gaap_ImpairmentOfIntangibleAssetsFinitelived    
Canterbury      
Intangible assets      
Intangible assets, net     144,356us-gaap_IntangibleAssetsNetExcludingGoodwill
/ us-gaap_BusinessAcquisitionAxis
= resx_CanterburyMember
In-process research and development costs (IPR&D)      
Intangible assets      
Indefinite-lived intangible assets 6,449,628us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
   
Impairment of IPR&D 3,035,000us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
   
Cosmeceutical | Canterbury      
Intangible assets      
Fair value of intangibles $ 0us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure
/ us-gaap_BusinessAcquisitionAxis
= resx_CanterburyMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= resx_CosmeceuticalMember